BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9553 related articles for article (PubMed ID: 129975)

  • 1. Membrane associated antigens of human malignant melanoma. I. Internal labeling, detergent solubilization and characterization by homologous antisera and polyacrylamide gel electrophoresis.
    Suter L; Sorg C; Müller C; Johannsen R; Macher E
    Z Immunitatsforsch Exp Klin Immunol; 1975 Oct; 150(4):318-26. PubMed ID: 129975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen.
    Heaney-Kieras J; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2310-6. PubMed ID: 7042082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopurification, characterization, and nature of membrane association of human melanoma-associated oncofetal antigen gp87 defined by monoclonal antibody 140.240.
    Liao SK; Kwong PC; Khosravi MJ
    J Cell Biochem; 1985; 27(3):303-16. PubMed ID: 3886678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
    Hamby CV; Liao SK; Kanamaru T; Ferrone S
    Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface antigenic characteristics of human melanoma cells defined by xenoantiserum raised against papain-solubilized melanoma-associated antigens.
    Ishii Y; Goldhofer W; Mavligit GM
    Gan; 1980 Dec; 71(6):881-8. PubMed ID: 7024033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
    Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
    Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of the H-2 antigen from hybrid cells of mouse mammary ascites tumor and mouse L cells at high cell concentrations in detergent.
    Kubota K; Takizawa K; Yamamoto T
    Jpn J Exp Med; 1978 Aug; 48(4):337-43. PubMed ID: 713135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization of complexes between tumor-associated and H-2 antigens from a tumor cell plasma membrane.
    Honeycutt PJ; Gooding LR
    Eur J Immunol; 1980 May; 10(5):363-70. PubMed ID: 7408937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprecipitation of membrane proteins of cultured human sarcoma cells.
    Grófová M; Forchhammer J; Lizonová A; Popovic M
    Neoplasma; 1981; 28(6):633-45. PubMed ID: 7339495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma tumor-specific antigens (II): Comparison of antigens from tumor cell plasma membranes of five melanoma patients.
    Khosravi M; Preddie E; Hartmann D; Lewis MG
    Cancer Biochem Biophys; 1980; 4(3):195-202. PubMed ID: 7438029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.
    Seigler HF; Metzgar RS; Mohanakumar T; Stuhlmiller GM
    Fed Proc; 1975 Jul; 34(8):1642-6. PubMed ID: 805717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma-associated antigen.
    Dixon WT; Demetrick DJ; Ohyama K; Sikora LK; Jerry LM
    Cancer Res; 1990 Aug; 50(15):4557-65. PubMed ID: 2369731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of tumor-associated antigens shed by human melanoma cells in culture.
    Boctor AM; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2121-5. PubMed ID: 7074593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 478.